ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#4)

Company

Vir Biotechnology, Inc.

Filed

January 10, 2022

Accession Number

0001072613-22-000038